LAUSR

Cutaneous small vessel vasculitis (CSVV) is, by definition, a form of single organ vasculitis that is isolated to the skin without systemic involvement. It is often mediated by immune complex deposition in small vessels [1]. CSVV is usually a benign disease with a good clinical outcome, and is differentiated from the other cutaneous vasculitides by its lack of systemic effects [2]. However, it can frequently relapse, increasing healthcare costs and patient distress [3,4]. Our search of the literature revealed one other case report associating dolutegravir with the new onset of CSVV [5]. However, that case was confounded by a high HIV viral load. Thus, to our knowledge, a case in a well controlled patient with suppressed viral load has yet to be introduced.